Related Experiment Video
Updated: Jul 10, 2026

04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
[Postoperative recurrence of a nodular goiter]
Vestnik Khirurgii Imeni I. I. Grekova
|October 31, 2007
Summary
Recurrent nodular goiter occurred in 26.8% of patients after surgery. Inadequate surgical techniques like lobe resection or node enucleation led to higher recurrence rates compared to thyroidectomy.
Area of Science:
- Endocrinology
- Surgical Oncology
- Pathology
Context:
- Nodular goiter management involves surgical intervention.
- Long-term outcomes of various surgical techniques for nodular goiter are crucial for clinical practice.
- Understanding recurrence patterns informs surgical decision-making.
Purpose:
- To evaluate the long-term recurrence rates of nodular goiter following different surgical interventions.
- To identify surgical methods associated with higher recurrence of nodular goiter.
- To determine the morphological characteristics of recurrent nodular goiter.
Summary:
- A 3-15 year follow-up of 649 patients with nodular goiter revealed a 26.8% recurrence rate.
- Nodular colloid goiter constituted the majority (87.4%) of recurrences.
- Operations involving significant preservation of thyroid tissue (lobe resection, node enucleation) showed higher recurrence rates (69.1%) compared to total thyroidectomy, which had no recurrences.
Impact:
- Findings suggest that less extensive surgeries like node enucleation and lobe resection are inadequate for preventing nodular goiter recurrence.
- Total thyroidectomy appears to be a more effective surgical approach for preventing recurrence.
- This study provides evidence to guide surgical choices in nodular goiter management to minimize recurrence.
Related Concept Videos
Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
